When compared with healthy young adults, in the elderly, this threshold is thought to be higher, leading to a loss of protein synthesis stimulation for a same amount of ingested proteins
Morgenstern R et al
The new 7.2mg dose produces approximately 20.7% weight loss, essentially matching Mounjaro 15mg, compared to 14.9% at the standard 2.4mg dose.
Patients who may benefit from discussing LDN with a Provn provider include: Those with significant needle anxiety that GLP-1 therapy would compound Those with a history of pancreatitis or other GLP-1 contraindications Those with autoimmune conditions who havent responded to conventional weight management approaches Those experiencing chronic inflammation that may contribute to metabolic difficulty Those who have tried GLP-1 therapy without success or with intolerable side effects LDN is taken as a daily oral capsule at bedtime, avoiding the storage, injection, and travel logistics associated with GLP-1 injectable therapy
This product has given my elderly cat a new lease of life, now 21 she has been on Solensia for around 2 years
The purity problem: "Research grade" peptides sold online range from roughly 70% to 99% purity